Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic...

Area of Science:

• Molecular Biology
• Genomics
• Cancer Research

Background:

• Metastasis is a primary driver of poor prognosis in cancers like hepatocellular carcinoma (HCC).
• Long non-coding RNAs (lncRNAs) are increasingly recognized for their critical roles in cellular processes, including cancer metastasis.

Purpose of the Study:

• To characterize lncRNA expression profiles in HCC cell lines with differing metastatic potentials.
• To identify specific lncRNAs involved in organ-specific metastasis (lung vs. lymph nodes) of HCC.

Main Methods:

• Assessed lncRNA and mRNA expression profiles in two HCC cell lines (HCCLM3 and HCCLYM-H2) using microarray analysis.
• Constructed coding-non-coding gene co-expression (CNC) networks.
• Performed gene set enrichment analysis (GSEA) and qRT-PCR to validate key lncRNA and mRNA expression.

Main Results:

• Identified 1,482 differentially expressed lncRNAs and 1,629 differentially expressed mRNAs between the cell lines.
• Found lincRNA-TSPAN8 and TSPAN8 highly expressed in lung-metastatic HCC cells, and RP5-1014O16.1 in lymph node-metastatic HCC cells.
• Highlighted specific upregulated and downregulated lncRNAs and mRNAs correlating with metastatic potential.

Conclusions:

• Provides the first detailed description of lncRNA expression profiles linked to organ-specific metastasis in HCC.
• Suggests numerous lncRNAs play significant roles in driving HCC cell metastasis to various organs.
• Proposes these lncRNAs as novel molecular biomarkers for therapeutic strategies against HCC metastasis.